Halozyme Therapeutics (HALO) Tops Q4 EPS by 2c ; Offers Guidance

Go back to Halozyme Therapeutics (HALO) Tops Q4 EPS by 2c ; Offers Guidance
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 68.99 +0.44 (0.64%)
Previous Close $68.55    52 Week High $18.39 
Open $69.34    52 Week Low $6.96 
Day High $69.81    P/E N/A 
Day Low $68.27    EPS $-0.58 
Volume 1,050,121